CVS Health Plans to Split Into Two Companies, Separating Aetna and Caremark From Its Pharmacy Chain
CVS Health plans to break itself in two, separating its Aetna insurance and Caremark pharmacy benefit businesses from its retail drugstore chain in a deal it expects to complete in the first half of 2028, according to an 8-K filed Wednesday.
The decision follows a comprehensive strategic review by the board, the company said. The separation is intended to be tax-free to CVS Health and its shareholders, who would own shares in both companies.
Who gets what
The healthcare solutions company, which will keep the CVS Health name in the interim, would combine Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health.
The second company, CVS Pharmacy, would hold the retail pharmacies, which CVS estimates at 9,000 locations, along with mail pharmacy, MinuteClinic and the Health100 technology services business.
David Joyner, chairman and CEO of CVS Health, would lead the healthcare solutions company as chairman and CEO. Prem Shah, currently group president, would become CEO of CVS Pharmacy. Other leadership and board positions will be named later.
Dividends and credit
CVS said both companies are expected to carry a solid investment-grade rating at separation, with strong free cash flow and the capacity to pay "an attractive dividend." It did not give dividend amounts.
"From a position of strength, and a focus on the long term, we plan to create two focused companies to improve consumer engagement, affordability, and care coordination," Joyner said.
What still has to happen
The split needs final approval from the CVS board, an effective Form 10 registration statement with the SEC and customary confirmation of its tax-free treatment. Until then, CVS said it will keep operating as it does today and deliver against its financial targets.
Goldman Sachs is lead financial and strategic advisor, Consello is also a financial and strategic advisor, and Wachtell, Lipton, Rosen & Katz is legal counsel.
The announcement came alongside third-quarter results, in which CVS raised its full-year adjusted EPS guidance to at least $8.20.
By the numbers
- Planned companies: 2 (healthcare solutions and CVS Pharmacy)
- Expected completion: first half of 2028
- Structure: intended tax-free spin-off to shareholders
- Healthcare solutions units: Aetna, CVS Caremark, CVS Specialty, Oak Street Health, Signify Health
Sources
- CVS Health Form 8-K announcing planned separation, filed Nov. 4, 2026 (accession 0001193125-26-446150)
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence.